移植诊断公司CareDx（CDNA）今日盘中股价大跌7.48%，主要受到两方面因素影响。
首先，CareDx最新公布的第二季度财报业绩不及市场预期。公司第二季度实现调整后每股收益0.1美元，低于分析师预期的0.12美元；营收为8670万美元，同样未能达到市场预期的9060万美元。尽管公司第二季度调整后EBITDA为910万美元，高于预期的612万美元，但整体业绩表现仍令投资者失望。
其次，投行杰富瑞在最新的研究报告中将CareDx的目标价从25美元下调至21美元。分析师的悲观态度进一步加剧了市场对CareDx未来发展前景的担忧。这两个因素共同导致了CareDx股价的大幅下挫。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.